Dermapharm Holding SE
Dermapharm Holding SE (XETRA: DMP) is trading at €39.35, about ₹4,299 at today's EUR/INR rate, as of 28 Sep 2026, 11:35 AM ET, up 0.77% today. Indian residents can buy Dermapharm from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€39.05
Today's high
€39.50
52 week low
€32.15
52 week high
€51.90
DMP opened at €39.05, closed previously at €39.05, and has traded between €32.15 and €51.90 over the past 52 weeks.
About
Dermapharm Holding SE, alongside its group companies, specializes in the off-patent branded pharmaceutical market, serving both German and international clients. The company’s operations are organized into three primary divisions: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It undertakes the development, manufacturing, licensing, marketing, and sale of branded generic medicines, over-the-counter remedies, non-prescription natural health solutions, and various other healthcare items. Dermapharm's product range covers areas such as vitamins, minerals, nutritional supplements, dermatology, allergology, pain and inflammation management, cardiovascular support, gynecology, and urology, prominently featuring brands like Dekristol, Dekristolvit, Allergovit, and Tromcardin. Additionally, the company provides medical devices including bite away and Herpotherm, as well as specific pharmaceutical preparations like Momekort, a nasal spray for allergy symptoms, and Azedil, which functions as a nasal spray or eye drop. It also manages the importation of originator pharmaceuticals under the axicorp brand. Furthermore, Dermapharm supplies herbal extracts and natural active ingredients for application in phytopharmaceuticals, nutraceuticals, and cosmetics. Its clientele encompasses pharmaceutical wholesalers, retail pharmacies, hospitals, and health food stores. Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
Key statistics
Avg. volume
30.09K
Market cap
€1.95B
P/E Ratio
14.21
Price-to-sales ratio
1.65
Enterprise value
€2.92B
Free cash flow yield
8.79%
Debt-to-equity ratio
2.18
Return on equity
22.38%
ROIC
10.15%
Beta
0.85
Dividend yield
2.24%
Last dividend
€0.88
Financial overview
Revenue
€1.16B
Earnings per share
€2.46
Free cash flow
€139.39M
Net profit margin
12.40%
Gross margin
34.73%
EBITDA
€314.31M
Revenue growth
-1.34%
Similar securities
This is not an investment recommendation
How to buy Dermapharm from India
Indian residents can buy Dermapharm shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Dermapharm and place an order
Find Dermapharm by name or by its ticker, DMP, and choose an order type. Dermapharm trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Dermapharm position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Dermapharm from India
Trading and taxes when buying Dermapharm from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Dermapharm’s current yield is 2.24%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Dermapharm stock?
Yes. Dermapharm (DMP) has been listed on XETRA since 2018, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Dermapharm share cost in rupees?
One Dermapharm share is €39.35 — about ₹4,299 at an EUR/INR rate of 109.26 on 27 Sep 2026. Both the Dermapharm price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Dermapharm from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Dermapharm shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Dermapharm price. Paasa issues a capital-gains statement for your return.
Does Dermapharm pay a dividend, and how is it taxed in India?
Yes. Dermapharm pays a dividend and the current yield is 2.24%; the last declared dividend was €0.88 per share, about ₹96.15. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Dermapharm from India?
XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.
Do I have to declare Dermapharm shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Dermapharm holding, its cost and its closing value.
How do I sell Dermapharm and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Dermapharm?
Yes. Dermapharm is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.